Cargando…

State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature

PURPOSE: Doses delivered to the urethra have been associated with an increased risk to develop long-term urinary toxicity in patients undergoing stereotactic body radiotherapy (SBRT) for prostate cancer (PCa). Aim of the present systematic review is to report on the role of urethra-sparing SBRT (US-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Guevelou, Jennifer, Bosetti, Davide Giovanni, Castronovo, Francesco, Angrisani, Antonio, de Crevoisier, Renaud, Zilli, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Topic Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632210/ https://www.ncbi.nlm.nih.gov/pubmed/37668718 http://dx.doi.org/10.1007/s00345-023-04579-6

Ejemplares similares

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple “MIRAGE”?
por: Bosetti, Davide Giovanni, et al.
Publicado: (2023)

Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
por: Dubouloz, Angèle, et al.
Publicado: (2018)

Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
por: Patel, Priyanka H., et al.
Publicado: (2019)

Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function
por: Le Guevelou, Jennifer, et al.
Publicado: (2023)

Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results
por: Zilli, Thomas, et al.
Publicado: (2020)

PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
por: le Guevelou, Jennifer, et al.
Publicado: (2021)

3D deep convolution neural network for radiation pneumonitis prediction following stereotactic body radiotherapy
por: Kapoor, Rishabh, et al.
Publicado: (2022)

Visualising the urethra for prostate radiotherapy planning
por: Richardson, Matthew, et al.
Publicado: (2021)

Tissue engineering of the urethra: where are we in 2019?
por: Chapple, Christopher
Publicado: (2019)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review
por: Foerster, Robert, et al.
Publicado: (2021)

Stereotactic radiotherapy for prostate cancer: A review and future directions
por: Syed, Yusef A, et al.
Publicado: (2017)

Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing
por: Greco, Carlo, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Selective sparing of bladder and rectum sub-regions in radiotherapy of prostate cancer combining knowledge-based automatic planning and multicriteria optimization
por: Alborghetti, Lisa, et al.
Publicado: (2023)

Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control
por: Chajon, Enrique, et al.
Publicado: (2013)

Stereotactic body radiotherapy for organ-confined prostate cancer
por: Katz, Alan J, et al.
Publicado: (2010)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function
por: Hwang, Mark E, et al.
Publicado: (2021)

A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer
por: Yoshimura, Takaaki, et al.
Publicado: (2021)

Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia
por: Castelli, Joel, et al.
Publicado: (2015)

Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study
por: Greco, Carlo, et al.
Publicado: (2022)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer
por: Pepin, Abigail N., et al.
Publicado: (2022)

LINAC‐based stereotactic radiosurgery for treatment of trigeminal neuralgia
por: Gerbi, Bruce J., et al.
Publicado: (2004)

Augmented Reality in Stereotactic Neurosurgery: Current Status and Issues
por: SATOH, Makoto, et al.
Publicado: (2023)

Future directions in systemic treatment of metastatic hormone-sensitive prostate cancer
por: Chen, Kenneth, et al.
Publicado: (2022)

“Urethral-Sparing” Robotic Radical Prostatectomy: Critical Appraisal of the Safety of the Technique Based on the Histologic Characteristics of the Prostatic Urethra
por: Asimakopoulos, Anastasios D., et al.
Publicado: (2023)

On the feasibility of cardiac substructure sparing in magnetic resonance imaging guided stereotactic lung radiotherapy
por: van der Pol, Luuk H.G., et al.
Publicado: (2022)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

Urethra-Sparing Robot-Assisted Simple Prostatectomy for Postoperative Antegrade Ejaculation
por: Choi, Sae Woong, et al.
Publicado: (2023)

MRI as a screening tool for prostate cancer: current evidence and future challenges
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer
por: Novikov, Sergey Nikolaevich, et al.
Publicado: (2016)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Editorial: Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
por: Vargo, John A., et al.
Publicado: (2015)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Stricture of the Urethra and Enlargement of the Prostate
Publicado: (1901)

Stricture of the Urethra and Enlargement of the Prostate
Publicado: (1902)

Villous adenoma of the prostatic urethra
por: Ho, SY, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7d0uaqf4ftrbrjvo0c8kt727lh